Download PDF
CC BY 4.0 · Journal of Clinical Interventional Radiology ISVIR
DOI: 10.1055/s-0044-1787785
Original Article

Safety and Efficacy of Lipiodol and N-Butyl Cyanoacrylate (N-BCA) Combination for Vascular Embolization

Raghunandan Prasad 
1   Amrita School of Medicine, Amrita Institute of Medical Sciences and Research Center, Amrita Vishwa Vidyapeetham, Faridabad, India
,
Pole Shivaji Marotrao
2   Department of Radiology, MGM Medical College and Hospital, Aurangabad, India
,
Virender Singh Sheorain
3   Division of Peripheral Vascular & Endovascular Sciences, Medanta-The Medicity Hospital, Gurgaon, India
,
Shivanand Gamanagatti
4   Department of Radiodiagnosis and Interventional Radiology, All India Institute of Medical Sciences, New Delhi, India
› Author Affiliations Funding None.
› Further Information
Also available at
   Permissions and Reprints

Abstract

Purpose The aim of this study was to evaluate the safety and efficacy of the combination of Lipiodol and N-butyl cyanoacrylate (N-BCA) for vascular embolization.

Methods Patients with various vascular pathologies, eligible for embolization using a combination of Lipiodol and N-BCA, were included in this ethical committee–approved prospective multicenter study. Adverse events (AEs) during the procedure and up to 30 days were recorded and categorized into minor or major (AE classification by the Society of Interventional Radiology). Depending on the targeted volume of vascular occlusion of the lesion, lesions were classified into four groups (group 1: <50% target volume; group 2: 50–75%; group 3: 75–99%, and group 4: 100%). Consistency between the targeted and actual vascular occlusion achieved after embolization was assessed.

Results One hundred and twenty-four patients were enrolled. All underwent at least one procedure, and 12 required a second procedure. No AEs were noted during the procedure, while 42 AEs occurred in 23 patients (18.5%) after and during the follow-up period. Two minor AEs in one patient (0.8%) were related to the mixture, and 26 AEs in 16 patients (12.9%) were related to the procedure (mostly minor A, 30.8% or B, 42.3%). The most frequent procedure-related AE was postembolization syndrome (4.8%). Nonfatal serious AEs related to the procedure occurred in two patients. The actual vascular occlusion was equal to or greater than the targeted volume in 119/135 lesions (88.1%) following the first procedure and in 11/13 lesions (84.6%) following the second procedure.

Conclusion Lipiodol and N-BCA combination is safe and highly effective for vascular embolization.

Keywords

embolization - N-BCA - Lipiodol

Ethical approval

The study was approved by the ethics committee of each site independently and authorized by the DCGI.




Publication History

Article published online:
08 July 2024

© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Behravesh S, Yakes W, Gupta N. et al. Venous malformations: clinical diagnosis and treatment. Cardiovasc Diagn Ther 2016; 6 (06) 557-569
    CrossrefPubMedGoogle Scholar
  • 2 Waguri N, Osaki A, Ikarashi S. et al. Simultaneous combined balloon-occluded retrograde transvenous obliteration and partial splenic embolization for gastric fundal varices. United European Gastroenterol J 2016; 4 (01) 62-69
    CrossrefPubMedGoogle Scholar
  • 3 Chevallier O, Comby PO, Guillen K. et al. Efficacy, safety and outcomes of transcatheter arterial embolization with N-butyl cyanoacrylate glue for non-variceal gastrointestinal bleeding: a systematic review and meta-analysis. Diagn Interv Imaging 2021; 102 (7–8): 479-487
    CrossrefPubMedGoogle Scholar
  • 4 Knight GM, Talwar A, Salem R, Mouli S. Systematic review and meta-analysis comparing prostatic artery embolization to gold-standard transurethral resection of the prostate for benign prostatic hyperplasia. Cardiovasc Intervent Radiol 2021; 44 (02) 183-193
    CrossrefPubMedGoogle Scholar
  • 5 Ladner TR, He L, Lakomkin N. et al. Minimizing bleeding complications in spinal tumor surgery with preoperative Onyx embolization via dual-lumen balloon catheter. J Neurointerv Surg 2016; 8 (02) 210-215
    CrossrefPubMedGoogle Scholar
  • 6 Esposito F, Lim C, Lahat E. et al. Combined hepatic and portal vein embolization as preparation for major hepatectomy: a systematic review. HPB (Oxford) 2019; 21 (09) 1099-1106
    CrossrefPubMedGoogle Scholar
  • 7 Leyon JJ, Littlehales T, Rangarajan B, Hoey ET, Ganeshan A. Endovascular embolization: review of currently available embolization agents. Curr Probl Diagn Radiol 2014; 43 (01) 35-53
    CrossrefPubMedGoogle Scholar
  • 8 Hu J, Albadawi H, Chong BW. et al. Advances in biomaterials and technologies for vascular embolization. Adv Mater 2019; 31 (33) e1901071
    CrossrefPubMedGoogle Scholar
  • 9 Louvel JP, Primard E, Henry J, Houlette C, Weinstein A, Janvresse A. Effects of the low-osmolality contrast medium Ioversol (Optiray) on renal function in a geriatric population. Acta Radiol 1996; 37 (06) 950-953
    CrossrefPubMedGoogle Scholar
  • 10 Papo J, Baratz M, Merimsky E. Infarction of renal tumors using isobutyl-2 cyanoacrylate and Lipiodol. AJR Am J Roentgenol 1981; 137 (04) 781-785
    CrossrefPubMedGoogle Scholar
  • 11 Tamatani S, Koike T, Ito Y, Tanaka R. Embolization of arteriovenous malformation with diluted mixture of NBCA. Interv Neuroradiol 2000; 6 (Suppl. 01) 187-190
    CrossrefPubMedGoogle Scholar
  • 12 Loffroy R, Guiu B, Cercueil JP, Krausé D. Endovascular therapeutic embolisation: an overview of occluding agents and their effects on embolised tissues. Curr Vasc Pharmacol 2009; 7 (02) 250-263
    CrossrefPubMedGoogle Scholar
  • 13 Rossi G, Mavrogenis AF, Rimondi E. et al. Selective arterial embolisation for bone tumours: experience of 454 cases. Radiol Med (Torino) 2011; 116 (05) 793-808
    CrossrefPubMedGoogle Scholar
  • 14 Jun CH, Kim KR, Yoon JH. et al. Clinical outcomes of gastric variceal obliteration using N-butyl-2-cyanoacrylate in patients with acute gastric variceal hemorrhage. Korean J Intern Med (Korean Assoc Intern Med) 2014; 29 (04) 437-444
    PubMedGoogle Scholar
  • 15 Di Stefano DR, de Baere T, Denys A. et al. Preoperative percutaneous portal vein embolization: evaluation of adverse events in 188 patients. Radiology 2005; 234 (02) 625-630
    CrossrefPubMedGoogle Scholar
  • 16 Hur S, Jae HJ, Lee M, Kim HC, Chung JW. Safety and efficacy of transcatheter arterial embolization for lower gastrointestinal bleeding: a single-center experience with 112 patients. J Vasc Interv Radiol 2014; 25 (01) 10-19
    CrossrefPubMedGoogle Scholar
  • 17 Cheng LF, Wang ZQ, Li CZ, Lin W, Yeo AE, Jin B. Low incidence of complications from endoscopic gastric variceal obturation with butyl cyanoacrylate. Clin Gastroenterol Hepatol 2010; 8 (09) 760-766
    CrossrefPubMedGoogle Scholar
  • 18 Khalilzadeh O, Baerlocher MO, Shyn PB. et al. Proposal of a new adverse event classification by the Society of Interventional Radiology Standards of Practice Committee. J Vasc Interv Radiol 2017; 28 (10) 1432-1437.e3
    CrossrefPubMedGoogle Scholar
  • 19 U.S. Food & Drug Administration. What is a serious adverse event?. Accessed June 9, 2023 at: https://www.fda.gov/safety/reporting-serious-problems-fda/what-serious-adverse-event
    PubMedGoogle Scholar
  • 20 Cil BE, Vargel I, Geyik S, Peynircioglu B, Cavusoglu T. Venous vascular malformations of the craniofacial region: pre-operative embolisation with direct percutaneous puncture and N-butyl cyanoacrylate. Br J Radiol 2008; 81 (972) 935-939
    CrossrefPubMedGoogle Scholar
  • 21 n-BCA Trial Investigators. N-butyl cyanoacrylate embolization of cerebral arteriovenous malformations: results of a prospective, randomized, multi-center trial. AJNR Am J Neuroradiol 2002; 23 (05) 748-755
    PubMedGoogle Scholar
  • 22 Bilreiro C, Donato P, Costa JF, Agostinho A, Carvalheiro V, Caseiro-Alves F. Varicocele embolization with glue and coils: a single center experience. Diagn Interv Imaging 2017; 98 (7–8): 529-534
    CrossrefPubMedGoogle Scholar
  • 23 Favard N, Moulin M, Fauque P. et al. Comparison of three different embolic materials for varicocele embolization: retrospective study of tolerance, radiation and recurrence rate. Quant Imaging Med Surg 2015; 5 (06) 806-814
    PubMedGoogle Scholar
  • 24 Miyamoto N, Naito I, Shimizu T, Yoshimoto Y. Efficacy and limitations of transarterial acrylic glue embolization for intracranial dural arteriovenous fistulas. Neurol Med Chir (Tokyo) 2015; 55 (02) 163-172
    CrossrefPubMedGoogle Scholar
  • 25 Sugiu K, Tokunaga K, Sasahara W. et al. Complications of embolization for cerebral arteriovenous malformations. Interv Neuroradiol 2004; 10 (Suppl. 02) 59-61
    CrossrefPubMedGoogle Scholar
  • 26 Liu HM, Huang YC, Wang YH. Embolization of cerebral arteriovenous malformations with n-butyl-2-cyanoacrylate. J Formos Med Assoc 2000; 99 (12) 906-913
    PubMedGoogle Scholar
  • 27 Barton PP, Waneck RE, Karnel FJ, Ritschl P, Kramer J, Lechner GL. Embolization of bone metastases. J Vasc Interv Radiol 1996; 7 (01) 81-88
    CrossrefPubMedGoogle Scholar
  • 28 Sun S, Lang EV. Bone metastases from renal cell carcinoma: preoperative embolization. J Vasc Interv Radiol 1998; 9 (02) 263-269
    CrossrefPubMedGoogle Scholar
  • 29 Sugawara S, Arai Y, Sone M. et al. Phase II trial of transarterial embolization using an n-butyl-2-cyanoacrylate/Lipiodol mixture (JIVROSG-0802). Cardiovasc Intervent Radiol 2019; 42 (04) 534-541
    CrossrefPubMedGoogle Scholar
  • 30 Kim R, Do YS, Park KB. et al. Therapeutic outcomes of embolotherapy of extremity bone intraosseous arteriovenous malformation with ethanol, coils, and n-butyl cyanoacrylate. J Vasc Surg 2021; 73 (06) 2090-2097.e5
    CrossrefPubMedGoogle Scholar
  • 31 Semeraro V, Vidali S, Borghese O. et al. Glue embolization in the management of rectus sheath hematomas. Vasc Endovascular Surg 2022; 56 (03) 269-276
    CrossrefPubMedGoogle Scholar
  • 32 Yata S, Ihaya T, Kaminou T. et al. Transcatheter arterial embolization of acute arterial bleeding in the upper and lower gastrointestinal tract with N-butyl-2-cyanoacrylate. J Vasc Interv Radiol 2013; 24 (03) 422-431
    CrossrefPubMedGoogle Scholar
  • 33 Hartmann A, Mast H, Mohr JP. et al. Determinants of staged endovascular and surgical treatment outcome of brain arteriovenous malformations. Stroke 2005; 36 (11) 2431-2435
    CrossrefPubMedGoogle Scholar
  • 34 Song JK, Gobin YP, Duckwiler GR. et al. N-butyl 2-cyanoacrylate embolization of spinal dural arteriovenous fistulae. AJNR Am J Neuroradiol 2001; 22 (01) 40-47
    PubMedGoogle Scholar
  • 35 Baltacioğlu F, Cimşit NC, Bostanci K, Yüksel M, Kodalli N. Transarterial microcatheter glue embolization of the bronchial artery for life-threatening hemoptysis: technical and clinical results. Eur J Radiol 2010; 73 (02) 380-384
    CrossrefPubMedGoogle Scholar